2 结果
TECHNICAL FIELD
The present disclosure relates to the treatment of excessive sleepiness and promotion of wakefulness in a subject. In particular, a method of treating hypersomnia (e.g., GABA.sub.A receptor mediated hypersomnia) using a GABA.sub.A receptor anagonist such as flumazenil (formulated,
TECHNICAL FIELD
The present disclosure relates to the treatment of excessive sleepiness and promotion of wakefulness in a subject. In particular, a method of treating hypersomnia (e.g., GABA.sub.A receptor mediated hypersomnia) using a GABA.sub.A receptor antagonist such as flumazenil (formulated,